Word: sanofi
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...pledged to rebuild a destroyed village, too. British American Tobacco plans to announce a substantial cash contribution to the relief drive this week. Companies whose products or services are desperately needed in affected countries - from drugmakers to utility companies - have come forward with in-kind contributions. French pharmaceutical giant Sanofi-Aventis' CEO Jean-François Dehecq personally made one such delivery. He and French Health Minister Philippe Douste-Blazy accompanied 70,000 cases of antibiotic, antibacterial and antidiarrheal drugs on an aid flight to Sri Lanka. Sanofi is donating a further €1 million to relief charities. Sanofi-Aventis...
...those who want to work more to do so. And consider the blatant interventionist. Sarkozy brokered the €2 billion state bailout of engineering giant Alstom, angering E.U. members who called it an unfair protectionist subsidy. He also coerced Franco-German pharmaceutical giant Aventis into merging with French competitor Sanofi-Synthelabo, neither of which is state-owned, to thwart takeover plans by Swiss rival Novartis. "I'm conservative, liberal-inclined and I believe in market economics," Sarkozy says. "But when an issue lands on my desk, I don't spend time wondering what [David] Ricardo, Adam Smith or [Friedrich] Hayek...
Even more exciting is a compound that appears to attack obesity through both the brain and the gut. Called rimonabant, and developed by Paris-based Sanofi, it is entering the final stages of human testing. Like Axokine and leptin, rimonabant was designed to make the body feel full. But scientists were pleasantly surprised to find that it also lowered triglyceride levels 15% and raised good cholesterol 22%--far more than would have been expected from weight loss alone. There is also evidence that patients on rimonabant may become more sensitive to the action of insulin, which can halt the progression...
...French are very territorial when it comes to champagne, ski resorts and, yes, pharmaceutical companies, which helps explain why the government strong-armed Sanofi-Synthelabo into sweetening a hostile bid for the Strasbourg-based Aventis--to create a French "national champion" in the pill market--and why the government warned Swiss drugmaker Novartis to stop fishing in the Rhine. Sanofi-Aventis will be the world's third largest pharmaceutical firm, after Pfizer and GlaxoSmithKline. But since the merger announcement, Sanofi's shares have tumbled, in part because investors think $66 billion is too high a price for Aventis, whose...
...Sanofi-Aventis deal may well be a side effect of the pharmaceutical industry's year-long market migraine, caused largely by expiring patents. There could be more mergers, but Merck, for one, seems to have hit on the less-than-acquisitive solution of partnering with companies that may have a blockbuster in the works. Last month it struck an alliance with Bristol-Myers Squibb to develop and sell an experimental diabetes drug, a joint venture similar to the one Merck formed with Schering-Plough for cholesterol treatments Zetia and Vytorin...